Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
TD-4208 175 mcg
Theravance Biopharma Ireland Umited
Cardiac Repolarization in Healthy Subjects
1 trial -
TD-5202
Theravance Biopharma Ireland Umited
Healthy
1 trial -
TEV-56286
Teva Pharma GmbH
Healthy Participants
1 trial -
TEV-56286 Test
Teva Pharma GmbH
Healthy Participants
1 trial -
TG-0054
Structure Therapeutics
Healthy
1 trial -
TGD001 SAD study in healthy volunteers
Lacuna Pharma Pty Ltd
A Phase I randomized, double-blind, placebo-controlled study to assess the safety and pharmacokinetics of single-ascending doses of TGD001 in healthy volunteers
1 trial -
TMS (MagVenture MagPro 100 with MagOption)
BRIGHT MINDS BIOSCIENCES INC.
Healthy Volunteers
1 trial -
TNX-102 SL
Tonix Pharmaceuticals Holding
Healthy Subjects (HS)
1 trial -
TNX-102 SL
Tonix Pharmaceuticals Holding
Healthy Subjects
1 trial -
TNX-102 SL 5.6 mg
Tonix Pharmaceuticals Holding
Healthy Subjects
1 trial -
TNX-102 SL Tablets at 2.8 mg
Tonix Pharmaceuticals Holding
Healthy Adults
1 trial -
TNX-1500
Tonix Pharmaceuticals Holding
Phase 1 First-in-human Study Involving Healthy Subjects
1 trial -
TNX-201 35 mg
Tonix Pharmaceuticals Holding
Healthy
1 trial -
TOP009
Substipharm
None - Healthy subjects
1 trial -
TP-03 (Lotilaner Ophthalmic Solution), 0.25%
Tarsus Pharmaceuticals
Healthy
1 trial -
TP-05 (lotilaner oral capsules)
Tarsus Pharmaceuticals
Healthy
1 trial -
TP-05 (lotilaner oral), fasted group
Tarsus Pharmaceuticals
Healthy
1 trial -
TRK-100STP (BERASUS LA)
Astellas Pharma Inc
Healthy
1 trial -
TV56286-MB-10193
Lacuna Pharma Pty Ltd
Healthy participant
1 trial -
TYRA-300-B01
Tyra Biosciences
Healthy
1 trial -
Tacrolimus
BRIGHT MINDS BIOSCIENCES INC.
Healthy Volunteers
2 trials -
Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
Takeda
Healthy
1 trial -
Talampanel
Teva Pharma GmbH
Healthy
1 trial -
Talampanel (non-radiolabeled), [14C] Talampanel
Teva Pharma GmbH
Healthy
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.